March 7, 2025 – The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss. The approval marks the first and only ...
Born with a rare eye condition severely affecting his sight ... two to three out of every 100,000 births. There are many types of LCA and these vary depending on which of the genes involved ...
Get Instant Summarized Text (Gist) Research is advancing treatments for rare eye diseases, which are a leading cause of untreatable blindness in Europe. Seven rare ocular conditions affecting the ...